I wrote briefly a few months ago about Altos Labs. It’s a new kind of biotech institute that is focused on cellular reprogramming. Now we know much more and it’s clear this is a huge deal. What’s in this article What is Altos Labs? | Cellular rejuvenation | Reprogramming oldness | Challenges | Altos Strategies | Analysis of …
All about Altos Labs & its $3B cellular rejuvenation push Read More »
Is 2022 going to be any better than 2020 or 2021 when it comes to things in general or for biomedical science? Related to the pandemic? It’s too soon to say but if I had to guess right now I’d venture an optimistic view that overall it’s going to be somewhat better by the end …
Weekly science reads: senescence, alt CRISPR, sickle cell update Read More »
What if you could get 8-year grants to do whatever biomedical research you wanted? This sounds like a dream for many of us in the life sciences, but the first news item this week is all about such a potential new funding approach. The item especially caught my eye as I’m going to be doing …
Weekly reads: hydra heads, iblastoids, new 8-year grants Read More »
A clever idea to try to use AI to make cellular machines has produced something being called xenobots. However, the research is getting overblown in some ways. What does this have to do with Zambonis? Read on. What are xenobots? A xenobot is supposed to be a cellular robot made from frog stem cells. The robot part …
If you celebrate the Thanksgiving holiday I hope you had a nice one and, right before it started a new article popped on the scene about the CRISPR babies. Before we discuss those three gene-edited people, who are now growing up into little kids, we hit a milestone on our YouTube Stem Cell Channel with …
Regenerative reads: 3 CRISPR babies, FDA warning, diabetes, pubs Read More »
Great ideas and talented scientists are not enough as biomedical research needs funding and here in the U.S. that means having R01 grant success. The trends since 1995 are slowly heading the wrong way. The average age of getting your first R01 grant keeps getting older. There is also still a bit of a possible …
Weekly reads: R01 grant trends, DPPA4, adult human neurogenesis debate Read More »
When I first learned about the multi-$10 million cord cell clinic deal between Duke and Cryo-Cell I couldn’t believe what I was reading. Duke’s involved in this? The problem: marketing unproven cells for kids Yes, this wasn’t some stem cell clinic operating out of a strip mall seeking to make big money off of injecting …
Vice tackles dicey Cryo-Cell Duke mega-million peds clinic plan Read More »
A piece on human tails and how we lost them caught my eye so I’ll start my weekly reads with that. This week I had the fewest Zoom meetings in ages, which allowed me to get more work done in my own lab and more reading. How about that? I even had some in-person meetings …
Recommended reads: a tale of human tails, heart reprogramming, pericytes, microglia Read More »
I love stem cell research but experiments that have practical possible future applications in medicine like for vision loss are especially interesting to me. On the other hand basic research on core transcription factor mechanisms like by MyoD also really grab me. We cover some of this stuff and other ground in today’s recommended reads. …
One of my favorite types of papers are those on stem cells and chromatin, and a new one in Current Biology caught my eye this week. My own lab website has the URL chromatin.com so that says something. You can also read more about our research here. Recommended reads: chromatin and stem cells, more Asymmetric …
Weekly recommended reads including asymmetric division & chromatin Read More »